We hypothesise that the administration of CSF-1 to promote augmentation of developmental macrophages associated with alveolarisation may reduce the need for damaging long-term oxygen therapy in preterm newborns and attenuate the developmental arrest of the lung associated with BPD. This evidence concerns the gene CSF1 and bronchopulmonary dysplasia.